| Dr Nina Izraylevich, DDS | |
|
4444 Geary Blvd, Suite 303, San Francisco, CA 94118-3048 | |
| (415) 386-5590 | |
| (415) 386-5592 |
| Full Name | Dr Nina Izraylevich |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 4444 Geary Blvd, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003946443 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 46612 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nina Izraylevich, DDS 4444 Geary Blvd, Suite 303, San Francisco, CA 94118-3048 Ph: (415) 386-5590 | Dr Nina Izraylevich, DDS 4444 Geary Blvd, Suite 303, San Francisco, CA 94118-3048 Ph: (415) 386-5590 |
News Archive
As flu season gets underway, public transport such as buses, trains and subway trains head the list of places where people worry about catching viruses and infections, according to new research by Microban.
Adipose tissue is not just a simple reservoir of energy for periods of food scarcity. It contributes significantly to regulation of the metabolism, releasing various molecules into the bloodstream, including microRNAs that modulate the expression of key genes in different parts of the organism, including the liver, pancreas, and muscles.
Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the detection of ductal carcinoma in situ (DCIS), a difficult to diagnose breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers.
Wolters Kluwer Health today announced that it has acquired Medknow PVT Ltd., a leading Scientific, Technical & Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world.
Omeros Corporation today announced dosing of the first patient in a second Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor being developed for the treatment of schizophrenia, Huntington's disease (HD) and other cognitive disorders. The Phase 2 trial will evaluate the tolerability, safety, pharmacokinetics and performance on a battery of tests in patients with symptomatic HD.
› Verified 7 days ago
Dr. Cuong Chi Ho, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 156 W Portal Ave # C, San Francisco, CA 94127 Phone: 415-564-2200 Fax: 415-520-6737 | |
Dr. Laila Kafi, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2827 Franklin St, San Francisco, CA 94123 Phone: 415-776-1900 Fax: 415-776-5504 | |
Dr. Ephraim W Aklilu, Dentist Medicare: Not Enrolled in Medicare Practice Location: 58 W Portal Ave # 106, San Francisco, CA 94127 Phone: 510-914-6903 | |
Dr. Kapil Deepak Kirpekar, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2494 Mission St, San Francisco, CA 94110 Phone: 415-873-8225 | |
Dr. Anh T Nguyen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2295 California St Apt 37, San Francisco, CA 94115 Phone: 408-209-4711 | |
Alireza Khoshvaghti, DDS Dentist Medicare: Medicare Enrolled Practice Location: 220 Montgomery St Ste 483, San Francisco, CA 94104 Phone: 415-398-6344 | |
Joseph Yang, MD, DMD, MBE Dentist Medicare: Medicare Enrolled Practice Location: 99 W Portal Ave, San Francisco, CA 94127 Phone: 415-661-6006 |